DLA Piper has advised two leading European debt funds, Rantum Capital and Proventus Capital, on their investment in a German family company, Cheplaharm. Both funds granted Cheplapharm Arzneimittel GmbH a subordinated loan, which represents the largest mezzanine financing, independent of banks, for a family-run, medium-sized company in Germany in 2016, to date.

Founded in 2013, Rantum Capital is an alternative asset manager based in Frankfurt am Main with a focus on private debt financing to companies of the German midmarket sector.

Proventus Capital is a family-owned, privately held investment company that has been active in Scandinavia and other European markets for over 40 years.

The DLA Piper team, led by partner Dr Wolfram Distler (Finance & Projects), comprised  partners Dr Christian Schoop (Litigation & Regulatory), Mike Danielewsky (Restructuring, all Frankfurt), Dr Thilo von Bodungen (IPT) and Florian Hirschmann (Corporate), counsel Dr Susanne Weckbach (IPT, all Munich), senior associates Dr Katalin Legradi (Finance & Projects, Frankfurt) and Silvio McMiken, as well as associates Tobias Schulz (both Corporate, Munich) and Sebastian Mai (Litigation & Regulatory, Frankfurt).